SCHEMBL1645858

SCHEMBL1645858

CC(=CC(=O)O)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8372870 1.00
SCHEMBL648808 1.00
SCHEMBL17670624 0.85 KDM4E (0.54)
SCHEMBL17670623 0.85 KDM4E (0.54)
SCHEMBL17775763 0.81
SCHEMBL195384 0.79
SCHEMBL11849467 0.79 KDM4E (0.58)
SCHEMBL2152750 0.79
SCHEMBL11849463 0.79 KDM4E (0.58)
SCHEMBL196084 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4296365-B1 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID VISOLIS INC (US) 2026-04-15 EP disclosed
EP-4296365-A2 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID Visolis, Inc. (US) 2023-12-27 EP disclosed
EP-3224368-B1 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID VISOLIS INC (US) 2023-10-25 EP disclosed
CN-112279744-B Method for the conversion of biologically derived mevalonate 维索利斯有限公司 2023-08-15 CN disclosed
US-11492339-B2 Processes for conversion of biologically derived mevalonic acid Visolis, Inc. (US) 2022-11-08 US disclosed
CN-107002104-B Method for conversion of biologically derived mevalonate 维索利斯有限公司 2021-08-17 CN disclosed
US-20210078966-A1 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID Visolis, Inc. 2021-03-18 US disclosed
CN-112279744-A Method for conversion of biologically derived mevalonate 维索利斯有限公司 2021-01-29 CN disclosed
US-10807963-B2 Processes for conversion of biologically derived mevalonic acid Visolis, Inc. (US) 2020-10-20 US disclosed
EP-3505523-A1 NEW RUBBER MIXTURES ARLANXEO Deutschland GmbH (DE) 2019-07-03 EP disclosed
WO-2013117762-A1 MICROGEL-CONTAINING TREAD MIXTURE FOR WINTER TYRES LANXESS DEUTSCHLAND GMBH (DE) 2013-08-15 WO disclosed
EP-2626384-A1 Bearing surface mixture containing micro-gel for winter tyres Lanxess Deutschland GmbH (DE) 2013-08-14 EP disclosed
EP-2186651-B1 Hydroxyl modified microgel lattices which can be stored safely for a long time LANXESS DEUTSCHLAND GMBH (DE) 2013-07-03 EP disclosed
EP-2491077-A1 NOVEL RUBBER MIXTURES Lanxess Deutschland GmbH (DE) 2012-08-29 EP disclosed
WO-2011048034-A1 NOVEL RUBBER MIXTURES LANXESS DEUTSCHLAND GMBH (DE) 2011-04-28 WO disclosed
EP-2311907-A1 New rubber mixtures LANXESS Deutschland GmbH (DE) 2011-04-20 EP disclosed
EP-2186651-A1 Hydroxyl modified microgel lattices which can be stored safely for a long time Lanxess Deutschland GmbH (DE) 2010-05-19 EP disclosed
EP-0673911-B1 Process for producing optically active carboxylic acids and chiral ligands for this purpose TAKASAGO PERFUMERY CO LTD (JP) 1999-01-20 EP disclosed
US-5563295-A HYDROGENATION OF OLEFINIC CARBOXYLIC ACID USING RUTHENIUM-PHOSPHINE COMPLEX CATALYST TAKASAGO INTERNATIONAL CORPORATION (JP) 1996-10-08 US disclosed
EP-0673911-A1 Process for producing optically active carboxylic acids and chiral ligands for this purpose Takasago International Corporation (JP) 1995-09-27 EP disclosed